Sientra Announces Closing of Previously Announced Sale of miraDry Business to 1315 Capital
SANTA BARBARA, Calif., June 11, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (Sientra or the Company), a medical aesthetics company uniquely focused on plastic surgeons, today announced it has closed the previously announced sale of its miraDry business to 1315 Capital, a healthcare growth equity firm investing in commercial stage companies across medical devices, healthcare services, and therapeutics.
- SANTA BARBARA, Calif., June 11, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (Sientra or the Company), a medical aesthetics company uniquely focused on plastic surgeons, today announced it has closed the previously announced sale of its miraDry business to 1315 Capital, a healthcare growth equity firm investing in commercial stage companies across medical devices, healthcare services, and therapeutics.
- Ron Menezes, President and Chief Executive Officer of Sientra stated: We are delighted to close our transaction with 1315 Capital.
- Our team is thrilled to continue building upon the miraDry business through excellence in service, support, training, and collaboration, said Arash Khazei, who is the Chief Executive Officer of the miraDry business.
- Actual results may differ from those set forth in this press release due to the risks and uncertainties inherent in the Companys business.